NCT06798896Phase 2Recruiting

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

Study sponsor: Supernus Pharmaceuticals, Inc. · SUPN

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-08Estimated

Enrollment · participants216Estimated

Source updated2026-06-01Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-06-01 · 2 fields changed

Enrollment · participant count

Recorded edit

− Previous value

count: 258; type: ESTIMATED

+ Updated value

count: 216; type: ESTIMATED

Primary completion date

Recorded edit

− Previous value

2026-10

+ Updated value

2027-08

Check registry source